3. Anxiety Disorders

This page is for educational purposes. Always verify with current clinical guidelines.

Learning Objectives

• Differentiate generalized anxiety disorder, panic disorder, social anxiety disorder, and specific phobia by their core diagnostic features
• Explain the neurobiological basis of anxiety, including the role of the amygdala, GABA, and serotonin
• Apply DSM-5 duration and symptom criteria to distinguish anxiety disorders from normal fear and from OCD/PTSD
• Compare first-line pharmacotherapy (SSRIs/SNRIs) and psychotherapy (CBT) options across anxiety disorders
• Recognize red flags that suggest a medical mimic of anxiety rather than a primary psychiatric disorder
• Identify common exam pitfalls in distinguishing anxiety disorders from each other and from mood disorders

Quick Answer

Anxiety disorders are a group of psychiatric conditions marked by excessive, persistent fear or worry that impairs daily functioning — they are the most common category of mental illness. The major types are generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and specific phobias, each defined by what triggers the anxiety and how it presents (chronic worry vs. discrete attacks vs. situational fear). Obsessive-compulsive disorder and PTSD were historically grouped here but now have their own DSM-5 chapters, though they remain closely related and commonly co-tested. First-line treatment combines cognitive-behavioral therapy (CBT) with SSRIs or SNRIs; benzodiazepines offer fast relief but are reserved for short-term or breakthrough use due to dependence risk. Recognizing these disorders matters because anxiety is highly treatable, yet frequently missed when it masquerades as physical illness.

Types of Anxiety Disorders

Anxiety disorders share a common thread — excessive fear or worry that is out of proportion to actual threat and causes real functional impairment — but they differ in trigger, time course, and presentation. Learning to sort patients into the right bucket is the exam skill here.

Generalized Anxiety Disorder (GAD)

Definition: GAD is excessive, difficult-to-control worry about multiple everyday domains (work, health, finances, relationships) occurring more days than not for at least 6 months, accompanied by physical symptoms.

Explanation: The worry in GAD isn't tied to one specific trigger — it floats from topic to topic. DSM-5 requires at least three of: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance. The chronicity (6+ months) is what separates GAD from ordinary situational stress.

Example: A student worries intensely about exams, then finances, then a minor headache — the content shifts but the underlying anxious state never resolves.

Real-World Example: Sarah, a college student, cannot stop worrying about her grades, her relationships, and her career even during breaks. She has trouble falling asleep because her mind keeps generating new "what if" scenarios, and she gets tension headaches most days.

Why It Matters: GAD is the anxiety disorder most likely to present in primary care with vague somatic complaints (fatigue, GI upset, muscle pain), so it's frequently missed or misattributed to a purely physical cause.

Common Misunderstanding: Students often think any worried patient qualifies for GAD. The diagnosis requires the 6-month duration and functional impairment — everyday stress before an exam does not meet criteria.

Panic Disorder

Definition: Panic disorder is recurrent, unexpected panic attacks followed by at least a month of persistent worry about having another attack or its consequences (behavior change to avoid triggers).

Explanation: A panic attack itself is a discrete episode — abrupt surge of intense fear peaking within minutes, with physical symptoms like palpitations, sweating, trembling, shortness of breath, chest pain, dizziness, and a sense of impending doom or dying. Panic attacks can occur in many anxiety disorders; panic disorder specifically requires attacks that are unexpected (not always cued by a known trigger) plus the secondary anticipatory anxiety.

Example: A patient has a panic attack in a grocery store with no obvious trigger, then starts avoiding grocery stores altogether for fear of "it happening again."

Real-World Example: John experiences sudden panic attacks while driving — racing heart, chest tightness, a feeling he's about to die — and now pulls over immediately whenever he feels the slightest chest sensation, eventually avoiding highway driving entirely.

Why It Matters: Panic attacks often present to the emergency department mimicking myocardial infarction or pulmonary embolism. Ruling out cardiac and pulmonary causes is essential before attributing symptoms to panic, especially in patients with risk factors.

Common Misunderstanding: Students conflate "having a panic attack" with "having panic disorder." A single panic attack during a genuinely frightening event (e.g., a car accident) is not panic disorder — the diagnosis needs recurrence plus the anticipatory dread or avoidance.

Social Anxiety Disorder (Social Phobia)

Definition: Marked, persistent fear of one or more social or performance situations in which the person is exposed to possible scrutiny by others, driven by fear of embarrassment or negative evaluation.

Explanation: Unlike GAD's diffuse worry, social anxiety is situation-specific — the fear centers on being watched, judged, or humiliated. Exposure to the feared situation almost always provokes anxiety, and patients avoid it or endure it with intense distress.

Example: A patient dreads speaking up in meetings, not because of the content but because of the fear that colleagues will notice her hands shaking or judge her negatively.

Real-World Example: Emily turns down party invitations and skips networking events because she fears saying something embarrassing, and when she cannot avoid a gathering, she experiences blushing, sweating, and a racing heart throughout.

Why It Matters: Social anxiety disorder often begins in adolescence and, if untreated, can shape major life decisions — choice of career, avoidance of higher education, social isolation — long before a patient ever seeks help.

Common Misunderstanding: Social anxiety disorder is often dismissed as "just shyness." Shyness doesn't typically cause the degree of functional impairment or physiological distress required for a DSM-5 diagnosis.

Specific Phobia and Agoraphobia

Definition: Specific phobia is marked fear of a circumscribed object or situation (heights, animals, blood, flying) that is actively avoided or endured with intense anxiety. Agoraphobia is fear of two or more situations where escape might be difficult or help unavailable if panic-like symptoms occur (e.g., public transport, open spaces, crowds, being outside the home alone).

Explanation: Both require the fear to be out of proportion to actual danger and to last 6+ months. Agoraphobia frequently co-occurs with panic disorder but is now coded as a separate diagnosis in DSM-5, since agoraphobia can exist without a history of panic attacks.

Example: A patient who refuses to fly for a job promotion despite knowing air travel is statistically far safer than driving illustrates the disproportionate nature of specific phobia.

Real-World Example: A patient with agoraphobia stops taking the subway after a panic attack there and gradually restricts her life to a few blocks around her home because "something might happen and no one could help."

Why It Matters: Untreated agoraphobia can become severely disabling, sometimes progressing to the person being unable to leave home at all — early exposure-based treatment prevents this downward spiral.

Common Misunderstanding: Agoraphobia is often assumed to mean "fear of open spaces" literally. It actually means fear of situations where escape or help would be difficult if symptoms strike — the common thread is loss of a perceived safety net, not the space itself.

OCD and PTSD — Related but Distinct

Obsessive-compulsive disorder (intrusive, unwanted obsessions relieved by repetitive compulsions) and PTSD (intrusive re-experiencing following a trauma, with avoidance, negative mood/cognition changes, and hyperarousal) were classified as anxiety disorders in DSM-IV but now have their own DSM-5 chapters because their underlying mechanisms and treatment nuances differ. They remain highly relevant here because exam questions frequently test the boundary between "is this anxiety, OCD, or PTSD?" A patient who washes hands repeatedly because of intrusive contamination thoughts has OCD, not GAD — the anxiety is a byproduct of the obsession-compulsion cycle, not free-floating worry.

Neurobiology of Anxiety

Definition: Anxiety disorders arise from dysregulated fear circuitry, primarily involving the amygdala (threat detection), prefrontal cortex (top-down regulation), and neurotransmitter systems including GABA, serotonin, and norepinephrine.

Explanation: The amygdala triggers the fight-or-flight response; in anxiety disorders, it tends to be hyperreactive while prefrontal regulation is diminished, so the brain over-responds to non-threatening stimuli and struggles to dampen the response. GABA is the brain's primary inhibitory neurotransmitter — benzodiazepines work by potentiating GABA-A receptors, producing rapid calming. Serotonin and norepinephrine pathways are targeted by SSRIs and SNRIs, which take weeks to remodel receptor sensitivity and reduce amygdala reactivity over time.

Why It Matters: This explains the clinical pattern students must memorize: benzodiazepines act in minutes (direct GABA potentiation) but SSRIs take 4-6 weeks (they require downstream receptor adaptation) — a frequently tested pharmacology fact.

Common Misunderstanding: Students often assume SSRIs work immediately like benzodiazepines. In reality, SSRIs can transiently increase anxiety in the first 1-2 weeks before benefit emerges, which is why short-term benzodiazepine bridging is sometimes used at treatment initiation.

Diagnosis and Treatment

Diagnosis relies on a thorough clinical interview mapping symptom duration, triggers, and functional impact, plus screening tools (GAD-7, Panic Disorder Severity Scale) and a physical workup to exclude medical mimics — thyroid dysfunction, arrhythmias, pheochromocytoma, caffeine or stimulant excess, and substance withdrawal can all produce anxiety-like symptoms and must be ruled out before anchoring on a psychiatric diagnosis.

Psychotherapy

Cognitive-behavioral therapy (CBT) has the strongest evidence base across all anxiety disorders. It combines cognitive restructuring (identifying and challenging catastrophic thoughts) with exposure techniques (gradual, systematic confrontation of feared situations to break the avoidance cycle). For panic disorder and phobias specifically, exposure-based components are considered essential, not optional.

Example: Rachel, who fears public speaking, works with a CBT therapist to identify her catastrophic thought ("everyone will see I'm incompetent"), test it against evidence, and gradually practices speaking in front of increasingly larger groups.

Pharmacotherapy

• SSRIs/SNRIs (e.g., sertraline, escitalopram, venlafaxine) are first-line for GAD, panic disorder, and social anxiety disorder. Start low, go slow — starting doses can transiently worsen anxiety.
• Benzodiazepines (e.g., lorazepam, clonazepam) act quickly but carry dependence, tolerance, and withdrawal risk — used short-term or for acute breakthrough symptoms, not as monotherapy long-term.
• Buspirone is a non-sedating option for GAD, useful when sedation or dependence risk is a concern, though it does not help acute panic.
• Beta-blockers (e.g., propranolol) can be used for performance-related social anxiety to blunt physical symptoms like tremor and tachycardia.

Example: Michael starts an SSRI for panic disorder; his psychiatrist warns him that anxiety may briefly worsen in week one and gives him a short benzodiazepine taper to bridge until the SSRI takes full effect around week 4-6.

Lifestyle Modifications

Regular aerobic exercise, sleep hygiene, caffeine reduction, and structured relaxation techniques (diaphragmatic breathing, mindfulness) are evidence-supported adjuncts — not replacements — for formal treatment. They matter most for sustaining remission and preventing relapse once symptoms are controlled.

Case Study

Jane, a 25-year-old marketing professional, avoids public speaking and networking events for fear of embarrassing herself, and reports blushing and a racing heart whenever she cannot avoid them. Her symptoms have persisted for over two years and now limit her career advancement.

Diagnosis: Social anxiety disorder.

Treatment plan: CBT with a strong exposure component, an SSRI to lower baseline physiological reactivity, and graded real-world practice (starting with small meetings, working up to presentations).

Outcome: After six months, Jane reports she can present to her team without a panic response, though she still notices mild nervousness beforehand — a realistic marker of good, not necessarily "perfect," treatment response.

Key Terms

Term	Definition	Related Concept
Generalized Anxiety Disorder (GAD)	Excessive, hard-to-control worry across multiple domains for 6+ months with associated physical symptoms	Chronic worry, somatic symptoms
Panic Attack	Abrupt surge of intense fear peaking within minutes, with physical symptoms and a sense of doom	Panic disorder, sympathetic activation
Panic Disorder	Recurrent unexpected panic attacks plus 1+ month of anticipatory anxiety or avoidance	Agoraphobia, catastrophic misinterpretation
Social Anxiety Disorder	Persistent fear of scrutiny or negative evaluation in social/performance situations	Avoidance, performance anxiety
Specific Phobia	Marked, disproportionate fear of a circumscribed object or situation	Exposure therapy, systematic desensitization
Agoraphobia	Fear of situations where escape or help is difficult if panic-like symptoms occur	Panic disorder, avoidance behavior
Amygdala	Brain structure central to threat detection and fear response generation	Fear circuitry, hyperreactivity
GABA	Brain's main inhibitory neurotransmitter; target of benzodiazepines	Benzodiazepines, rapid anxiolysis
Exposure therapy	CBT technique of gradual, systematic confrontation with feared stimuli to reduce avoidance	CBT, desensitization
SSRIs/SNRIs	First-line antidepressant classes also used for anxiety disorders; act on serotonin/norepinephrine	Pharmacotherapy, delayed onset
GAD-7	Validated 7-item screening/severity scale for generalized anxiety	Screening tools, primary care

Common Mistakes

Misconception: Any patient who feels anxious or worried has an anxiety disorder. Why it's wrong: Anxiety is a normal, adaptive emotion. DSM-5 anxiety disorders require the anxiety to be disproportionate to actual threat, persistent (specific duration thresholds per disorder), and cause significant distress or functional impairment. Correct understanding: A diagnosis requires meeting duration criteria (e.g., 6 months for GAD and specific phobia) and demonstrating real interference with work, relationships, or daily functioning — not just the subjective experience of worry.

---

Misconception: Panic attacks and panic disorder are the same thing. Why it's wrong: Panic attacks are a symptom that can occur in many anxiety disorders, PTSD, depression, or even without any disorder at all (e.g., after a genuine near-miss accident). Correct understanding: Panic disorder specifically requires recurrent, unexpected attacks plus at least a month of persistent worry about future attacks or maladaptive behavior change (avoidance) related to them.

---

Misconception: Benzodiazepines should be first-line, long-term treatment for anxiety disorders because they work fastest. Why it's wrong: While benzodiazepines relieve symptoms within minutes to hours, long-term use carries significant risks of tolerance, physical dependence, and difficult withdrawal, and they do not address the underlying cognitive-behavioral patterns driving the disorder. Correct understanding: SSRIs/SNRIs plus CBT are first-line for sustained treatment; benzodiazepines are reserved for short-term bridging or acute breakthrough symptoms under close monitoring.

Comparison and Connections

Feature	Generalized Anxiety Disorder	Panic Disorder	Social Anxiety Disorder	OCD
Core feature	Chronic, diffuse worry	Recurrent unexpected panic attacks	Fear of social scrutiny/judgment	Intrusive obsessions + compulsions
Trigger pattern	Multiple, shifting topics	Often no clear external trigger	Specific social/performance situations	Specific intrusive thought themes (contamination, symmetry, harm)
Minimum duration	6 months	1 month of anticipatory anxiety after attacks	6 months	Time-consuming (>1 hr/day) or causing impairment
DSM-5 chapter	Anxiety disorders	Anxiety disorders	Anxiety disorders	Obsessive-compulsive and related disorders
First-line treatment	SSRI/SNRI + CBT	SSRI + CBT with exposure/interoceptive exposure	SSRI + CBT with exposure	SSRI (often higher doses) + exposure and response prevention (ERP)

Practice Questions

Recall

1. What is the minimum symptom duration required to diagnose GAD? Guidance: At least 6 months of excessive worry occurring more days than not, plus associated physical/cognitive symptoms.

2. Name three physical symptoms commonly seen during a panic attack. Guidance: Any three of palpitations, sweating, trembling, shortness of breath, chest pain, dizziness, or a sense of impending doom.

Understanding

3. Why do SSRIs sometimes worsen anxiety in the first one to two weeks of treatment before improving it? Guidance: SSRIs initially increase synaptic serotonin, which can transiently overstimulate certain receptors before downstream receptor adaptation occurs over several weeks, producing the eventual anxiolytic effect.

4. Why is agoraphobia now classified separately from panic disorder in DSM-5, even though the two frequently co-occur? Guidance: Agoraphobia can develop and exist independently of panic attacks — a person may fear situations where escape is difficult without ever having had a panic attack — so DSM-5 recognizes it as its own diagnostic entity with its own criteria.

Application

5. A 34-year-old presents to the ED with chest pain, palpitations, sweating, and a feeling of impending doom that peaked within 10 minutes and resolved in 20. What should be ruled out before diagnosing a panic attack? Guidance: Cardiac causes (MI, arrhythmia), pulmonary embolism, hyperthyroidism, and substance-induced causes (stimulant use, caffeine excess, withdrawal) should be excluded with appropriate workup (ECG, troponin, TSH, toxicology) before attributing symptoms to panic.

6. A patient with social anxiety disorder is offered CBT but says she "just needs medication to calm her nerves before presentations." How would you address this? Guidance: Explain that a beta-blocker like propranolol can blunt performance-related physical symptoms situationally, but for durable improvement in the underlying fear of judgment, CBT with exposure — and typically an SSRI for baseline reactivity — offers better long-term outcomes than symptom suppression alone.

Analysis

7. Compare the roles of the amygdala and prefrontal cortex in anxiety disorders, and explain how this circuitry supports the rationale for both pharmacotherapy and CBT. Guidance: The amygdala drives threat detection and fear responses; anxiety disorders involve amygdala hyperreactivity coupled with reduced prefrontal regulation. SSRIs reduce amygdala reactivity over time via serotonergic modulation, while CBT strengthens prefrontal top-down control through repeated cognitive reframing and exposure — the two treatments target complementary parts of the same circuit.

8. A patient with contamination-related intrusive thoughts and compulsive handwashing is initially diagnosed with GAD. Explain why this is likely incorrect and what the correct diagnostic approach would be. Guidance: The anxiety here is not free-floating worry across multiple domains but is specifically generated by intrusive obsessions and relieved (temporarily) by ritualistic compulsions — this pattern is diagnostic of OCD, not GAD. The clinician should assess for the obsession-compulsion cycle, time consumption, and whether compulsions are performed to reduce distress from a specific intrusive thought.

FAQ

Q: What's the real difference between normal worry and generalized anxiety disorder? Normal worry is proportionate, tied to an actual stressor, and resolves once the stressor passes. GAD involves worry that is excessive relative to the actual likelihood or impact of the feared outcome, spreads across unrelated topics, persists for 6+ months, and comes with physical symptoms like muscle tension or sleep disturbance that impair daily functioning.

Q: Can someone have more than one anxiety disorder at the same time? Yes — comorbidity is the norm rather than the exception. Panic disorder frequently co-occurs with agoraphobia, and GAD often coexists with social anxiety disorder or major depression. Clinicians should screen broadly rather than stopping at the first diagnosis that fits.

Q: Why are benzodiazepines not considered first-line long-term treatment? They provide fast relief by potentiating GABA, but tolerance develops, effective doses tend to rise, and abrupt discontinuation can cause dangerous withdrawal (including seizures). They also don't teach the brain new coping patterns the way CBT does, so symptoms often return once the medication stops.

Q: How long does it take for SSRIs to work for anxiety? Typically 4 to 6 weeks for a noticeable anxiolytic effect, sometimes longer to reach full benefit. Patients should be counseled about this delay and the possibility of transient symptom worsening in the first week or two, so they don't discontinue prematurely.

Q: Is exposure therapy the same as "just facing your fears" without professional guidance? No. Exposure therapy is a structured, graded process — building a fear hierarchy from least to most distressing situations, ensuring the patient stays in the situation long enough for anxiety to naturally decline (habituation), and pairing exposures with cognitive strategies. Unstructured or overwhelming exposure can backfire and reinforce avoidance.

Quick Revision

• GAD: excessive worry across multiple domains, 6+ months, with physical symptoms (restlessness, fatigue, muscle tension, sleep disturbance)
• Panic disorder: recurrent unexpected panic attacks + 1+ month of anticipatory anxiety/avoidance
• Panic attack ≠ panic disorder — attacks can occur in many conditions
• Social anxiety disorder: fear of scrutiny/judgment in social or performance situations
• Specific phobia: disproportionate fear of a circumscribed trigger; agoraphobia: fear of situations where escape/help is hard
• OCD and PTSD have their own DSM-5 chapters but remain closely related and commonly co-tested
• Amygdala hyperreactivity + reduced prefrontal regulation underlies the fear circuitry in anxiety disorders
• GABA is targeted by benzodiazepines (fast-acting); serotonin/norepinephrine are targeted by SSRIs/SNRIs (delayed onset, 4-6 weeks)
• First-line treatment across anxiety disorders: SSRI/SNRI + CBT (with exposure component)
• Benzodiazepines: fast but risk tolerance/dependence — short-term or breakthrough use only
• Always rule out medical mimics (thyroid disease, arrhythmia, pheochromocytoma, substance use/withdrawal) before diagnosing a primary anxiety disorder
• Beta-blockers help situational performance anxiety symptoms but don't treat the underlying disorder

Related Topics

Prerequisites: Introduction to Psychiatry, basic neurobiology of neurotransmitters, DSM-5 diagnostic framework, mental status examination

Related Topics: Obsessive-Compulsive and Related Disorders, Trauma- and Stressor-Related Disorders (PTSD), Mood Disorders, Psychopharmacology (SSRIs/SNRIs/benzodiazepines), Cognitive-Behavioral Therapy

Next Topics: Obsessive-Compulsive Disorder, Trauma and PTSD, Mood Disorders, Clinical Psychopharmacology